Riskpilot← Back to searchSign inGet full accessIM Club ApS
APSActiveCVR 37206547Egebækvej 98Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2015— employees
Revenue 2025
DKK -11K
-6% vs 2024
EBITDA margin
100.0%
+6% vs 2024
Equity ratio
58.0%
Financial strength
Net profit 2025
DKK 1,8M
+2% vs 2024
| Revenue | DKK -11K | -6% |
| EBITDA | DKK -11K | +6% |
| Net profit | DKK 1,8M | +2% |
| Total assets | DKK 6,9M | -16% |
| Equity | DKK 4M | +28% |
| Employees | — | — |
Legal name
IM Club ApS
CVR number
37206547
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
5. november 2015
Share capital
DKK 121.700
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er at eje kapitalandele i Intramedic Holding A/S samt al virksomhed, som efter direktionens skøn er beslægtet hermed.
Address
Egebækvej 98
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -6 | -23 | -10 | -11 | -5 | -26 | -19 | -11 | -11 | -11 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -6 | -23 | -10 | -11 | -5 | -26 | -19 | -11 | -11 | -11 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -6 | -23 | -10 | -11 | -5 | -26 | -19 | -11 | -11 | -11 |
| Net financials | 0 | 594 | -169 | 1.083 | 1.573 | 456 | 2.227 | 140 | 1.764 | 1.793 |
| Profit before tax | -6 | 571 | -178 | 1.072 | 1.568 | 430 | 2.208 | 129 | 1.753 | 1.782 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -6 | 571 | -178 | 1.072 | 1.568 | 430 | 2.208 | 129 | 1.753 | 1.782 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6.858 | 6.824 | 6.772 | 7.744 | 6.927 | 6.818 | 7.087 | 6.858 | 8.158 | 6.887 |
| Equity | 494 | 835 | 572 | 1.358 | 2.439 | 2.224 | 2.332 | 1.961 | 3.113 | 3.996 |
| Long-term debt | 5.890 | 5.983 | 5.142 | 5.613 | 3.442 | 4.239 | 4.706 | 3.574 | 2.731 | 981 |
| Short-term debt | 474 | 6 | 1.058 | 773 | 1.046 | 355 | 49 | 1.323 | 2.314 | 1.910 |
| Total debt | 6.364 | 5.989 | 6.200 | 6.386 | 4.488 | 4.594 | 4.755 | 4.897 | 5.045 | 2.891 |
EBITDA margin
-1063500.0%
This company
15.8%
Market median
-6731113% vs market
20162025
Equity ratio
58.0%
This company
38.2%
Market median
+52% vs market
20162025
Return on equity
44.6%
This company
18.4%
Market median
+142% vs market
20162025
Net profit margin
178217400.0%
This company
8.1%
Market median
+2200214715% vs market
20162025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20162025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20162025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-11-05 – 2016-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LS Unofficial title | Unofficial title | 2021 | — | — |
CL Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
FB Management | Management | 2015 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
INTRAMEDIC HOLDING A/S | Company | 20.0% | 0.0% | 2022 |
IM INVEST ApS | Company | 20.0% | 33.3% | 2017 |
CARDIOPHARMA ApS | Company | 10.0% | 33.3% | 2017 |
| Individual | 10.0% | 0.0% | 2017 | |
| Individual | 5.0% | 0.0% | 2015 | |
| Individual | 5.0% | 0.0% | 2015 | |
| Individual | 5.0% | 0.0% | 2017 | |
| Individual | 5.0% | 0.0% | 2015 | |
| Individual | 5.0% | 0.0% | 2015 | |
| Individual | 0.0% | 5.0% | 2017 | |
| Individual | 5.0% | 0.0% | 2015 | |
| Individual | 10.0% | 0.0% | 2017 | |
EDSVIKEN ApS | Company | 10.0% | 33.3% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CARDIOPHARMA ApS
IM Club ApS Board members of IM Club ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Skanvig Bramhelft | Unofficial title | 0 companies |
| Casper Lyngbo Hjort | Chief Executive Officer | 0 companies |
| Frans Boch | Management | 0 companies |